GENMAB |
Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
| 1,986 DKK | +63.15% |
|
+4.14% | +14.24% |
| May. 03 | GENMAB : A good start to 2024; guidance unchanged |  |
| May. 03 | Genmab Posts Q1 Net Profit Surge; Revenue Jumps | MT |
"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
End-of-day quotes
End-of-day quotes
Sector Bio Therapeutic Drugs
| Capi. | Sales growth | Profitability | Finances | EV / Sales | P/E ratio | |
|---|---|---|---|---|---|---|
| 109B | ||||||
| 105B | ||||||
| 22.25B | - | |||||
| 22.09B | - | |||||
| 17.58B |
- Stock Market
- Equities
- GMAB Stock
- Stock
- Charts Genmab
- Sector Chart